DOSSIER · UPDATED 18 NOV 2025

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer. Verismo’s cellular therapy, known as KIR-CAR, is designed to provide a “natural stimulation” to T cells…

verismotherapeutics.com ↗Claim this profile
Founded
2020
Headcount
22
Open roles
0
Last raised
Seed · $4M
SECTION I · THE BRIEF

Inside Verismo Therapeutics

Brief #06803Updated 18 NOV 2025PHILADELPHIAMEDICAL ORGANIZATIONSSEED
Employbl Dossier

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer. Verismo’s cellular therapy, known as KIR-CAR, is designed to provide a “natural…

Founded
2020
Headcount
22
Open roles
0
Last raised
Seed · $4M
Section II · Premium ProfileMembers only
  • 01Engineering interview process at Verismo TherapeuticsLocked
  • 02Tech stack & infrastructure choicesLocked
  • 03Culture & day-to-day work styleLocked
  • 04Why join now vs. 6 months from nowLocked
  • 05Hiring focus & open headcount by teamLocked
  • 06Comp philosophy and band contextLocked
Open Verismo Therapeutics briefSign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Michael Milone

Michael Milone

Researcher

Cabaletta BioVerismo TherapeuticsPerelman School of MedicinePenn Medicine University of Pennsylvania Health SystemHome DepotUniversity of Pennsylvania (Penn)Rutgers New Jersey Medical SchoolUMDNJ – Graduate School of Biomedical SciencesStevens Institute of TechnologyUniversity of Pennsylvania (Penn)
Donald Siegel

Donald Siegel

CEO at Equipment Savers Fleet Services

Siegel OilEquipment Savers Fleet ServicesColorado Advisory BoardVerismo TherapeuticsUniversity of the Pacific
Bryan Kim

Bryan Kim

CEO at Verismo Therapeutics

Transcure Bio VenturesVerismo TherapeuticsHipset
OPEN ROLES

Hiring at Verismo Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $44,200,000

Verismo Therapeutics Funding Rounds

  • Seed

    $4,050,000

  • Seed

    $4,050,000

    Seed Investors

    Institute for Follicular Lymphoma Innovation

  • Grant

    $150,000

  • Grant

    $150,000

    Grant Investors

    ScaleReady

  • Seed

    $17,000,000

  • Seed

    $17,000,000

    Seed Investors

    DongKoo Bio & Pharma Co.
    Hong Leong Bank

  • Seed

    $7,000,000

  • Seed

    $7,000,000

    Seed Investors

    BRV Capital Management

  • Seed

    $16,000,000

  • Seed

    $16,000,000

Funding info provided by Diffbot.
TAGS

Categorized in

Company Collections

These are collections Verismo Therapeutics is a part of. Click on the collection name to view similar companies.

Verismo Therapeutics' Industries

Verismo Therapeutics' Tech Stack

LOCATIONS

Where they work

Verismo Therapeutics Headquarters Location

3675 Market St Suite 200, Philadelphia, PA, 19104

Loading map…